MLTXMOONLAKE IMMUNOTHERAPEUTICS
CUSIP 61559X104 · common stock
2 tracked investors held MOONLAKE IMMUNOTHERAPEUTICS (MLTX) at the end of Q3 2026, worth $6.1M in total. The largest holder was Stanley Druckenmiller, with 0.1% of its portfolio. Stanley Druckenmiller opened a new position this quarter.
Holders · Q3 2026
2
New holders
1
Value held
$6.1M
Quarter-end price (est.)
$11.70
Investors holding MLTX · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| Stanley Druckenmiller Duquesne Family Office LLC | 0.13% | 494,000 | $5.8M | NEW |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.01% | 27,000 | $315.9K | HOLD |